GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » LumiraDx Ltd (OTCPK:LMDWF) » Definitions » Current Deferred Revenue

LumiraDx (LumiraDx) Current Deferred Revenue : $15.60 Mil (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LumiraDx Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

LumiraDx's current deferred revenue for the quarter that ended in Jun. 2023 was $15.60 Mil.

LumiraDx Current Deferred Revenue Historical Data

The historical data trend for LumiraDx's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LumiraDx Current Deferred Revenue Chart

LumiraDx Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Current Deferred Revenue
- 45.80 19.47 17.30

LumiraDx Quarterly Data
Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.53 30.69 17.30 15.44 15.60

LumiraDx Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of LumiraDx's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LumiraDx (LumiraDx) Business Description

Traded in Other Exchanges
Address
C/o Ocorian Trust (Cayman) Ltd, Windward 3, P.O. Box 1350, Regatta Office Park, Grand Cayman, CYM, KY1-1108
LumiraDx Ltd is a next-generation point of care diagnostics company. It manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. Geographical presence in United States, Italy, UK, Germany, Colombia, Sweden and Other countries. Majority revenue derives from U.S.